FFA
GSK icon

Frazier Financial Advisors’s GSK GSK Stock Holding History

Frazier Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21
Closed -$1.16K – 715
2026
Q1 		$1.16K Sell
21
-59
-74% -$3.2K ﹤0.01% 609
2025
Q4 		$3.92K Buy
+80
New +$3.73K ﹤0.01% 497
2024
Q4 		– Sell
-215
Closed -$8.79K – 748
2024
Q3 		$8.79K Sell
215
-259
-55% -$10.6K 0.01% 404
2024
Q2 		$18.2K Buy
474
+239
+102% +$10.1K 0.01% 309
2024
Q1 		$10.1K Buy
235
+177
+305% +$7.3K 0.01% 410
2023
Q4 		$2.15K Buy
+58
New +$2.08K ﹤0.01% 665

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Frazier Financial Advisors's GSK Position: Q2 2026 in Review

Frazier Financial Advisors sold out of GSK (GSK) in Q2 2026, closing a stake of 21 shares — an estimated $1.16K sold.

Frazier Financial Advisors first reported a position in GSK in Q4 2023 and held it in 6 quarters. The position peaked at $18.2K in Q2 2024. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Frazier Financial Advisors reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Frazier Financial Advisors sold 21 GSK shares in Q2 2026, an estimated $1.16K.
  • Frazier Financial Advisors first reported a position in GSK in Q4 2023 and held it in 6 quarters.
  • Frazier Financial Advisors's GSK position peaked at $18.2K in Q2 2024.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.